Fig. 3From: Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathwayFFA at 50 μM promoted osteogenic differentiation of hBMMSCs in vivo. a H&E staining of PM, PM+DMSO, and PM+FFA groups. b Masson’s staining of PM, PM+DMSO, and PM+FFA groups. PM, proliferation media; FFA, flufenamic acid; hBMMSC, human bone marrow-derived mesenchymal stem cell; H&E, hematoxylin and eosinBack to article page